GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,856,000 | +300.9% | 31,611 | +113.3% | 0.00% | – |
| Q4 2020 | $1,710,000 | -8.4% | 14,821 | -22.7% | 0.00% | – |
| Q3 2020 | $1,867,000 | -22.9% | 19,175 | -2.9% | 0.00% | – |
| Q2 2020 | $2,422,000 | +26.5% | 19,738 | -9.7% | 0.00% | – |
| Q1 2020 | $1,914,000 | +96.1% | 21,855 | +134.2% | 0.00% | – |
| Q4 2019 | $976,000 | -2.4% | 9,333 | +7.3% | 0.00% | – |
| Q3 2019 | $1,000,000 | -34.1% | 8,694 | -1.3% | 0.00% | – |
| Q2 2019 | $1,518,000 | +7.7% | 8,806 | +5.3% | 0.00% | – |
| Q1 2019 | $1,409,000 | +70.0% | 8,359 | -1.8% | 0.00% | – |
| Q4 2018 | $829,000 | +262.0% | 8,510 | +277.4% | 0.00% | – |
| Q3 2017 | $229,000 | +8.0% | 2,255 | +6.7% | 0.00% | – |
| Q2 2017 | $212,000 | -70.6% | 2,114 | -79.6% | 0.00% | – |
| Q4 2015 | $721,000 | – | 10,387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |